Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine

Clinical trial NCT02270944 · COMPLETED

Trial details

NCT number: NCT02270944
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Infections, Streptococcal Streptococcal Infections

Start date: 2014-11-20
Primary completion: 2015-04-23
Enrollment: 1053

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.